A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
This prospective pharmacoepidemiological study examined treatment and outcomes in patients converted to sirolimus (SRL) after renal transplantation. 484 subjects in 36 centres in 7 countries were followed for up to 5 years. Principal reasons for conversion were declining graft function (146/484, 30%...
Saved in:
Main Authors: | Bertram L. Kasiske, Bjorn Nashan, Maria Del Carmen Rial, Pablo Raffaele, Graeme Russ, Josep Campistol, Mark D. Pescovitz, Paul A. Keown |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/107180 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
by: Massimiliano Veroux, et al.
Published: (2013-01-01) -
Dramatic Response to Sirolimus in Lymphangioleiomyomatosis
by: Dmitry Rozenberg, et al.
Published: (2013-01-01) -
Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
by: Somayyeh Hashemian, et al.
Published: (2020-01-01) -
Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
by: Séin O'Connell, et al.
Published: (2012-01-01) -
Sirolimus for the Treatment of Airway Obstruction due to Indolent T-Lymphoblastic Proliferation
by: Eric Moughames, et al.
Published: (2019-01-01)